Schrödinger, a global leader in computational chemistry, has adopted the Sapio Sciences Platform to improve data management, enhance lab efficiency, and accelerate the discovery of novel molecules at its internal wet lab.

Dr. Rajesh Kumar, Senior Director of Drug Discovery at Schrödinger, commented: “Sapio’s solution has allowed us to digitize critical lab functions, improve efficiency, and ensure seamless sample traceability across our research and discovery processes. By unifying data and automating workflows, we’re able to focus on advancing our research with greater speed and confidence.”

Sapio’s platform provides Schrödinger with improved visibility across the discovery process, enabling real-time tracking and optimized resource use. The platform also ensures comprehensive data traceability, simplifying audits and regulatory filings, while access to historical data optimizes resource allocation and planning. Finally, Sapio facilitates long-term knowledge retention by centralizing critical research data for easy retrieval and support of future initiatives.

Mike McCartney, Chief Commercial Officer at Sapio Sciences, commented: “Schrödinger’s adoption of the Sapio Platform highlights the increasing demand for configurable informatics solutions that unify complex lab environments. By eliminating data silos and improving lab efficiency, we’re enabling Schrödinger to accelerate drug discovery and drive innovation.”